Dianicline

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDianicline
Drug Alias Name迪安克林SSR-591813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor; alpha4/beta2 agonists
TargetsNeuronal acetylcholine receptor alpha4/beta2 complex
Therapy Area/IndicationsTobacco Use CessationSmoking Cessation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsTobacco Use CessationSmoking Cessation

Other Information

ATC CodeN/A
Related LinksN/A